Sector
PharmaceuticalsOpen
₹45.25Prev. Close
₹46.11Turnover(Lac.)
₹1.41Day's High
₹47.47Day's Low
₹45.1952 Week's High
₹91.8752 Week's Low
₹40.4Book Value
₹11.53Face Value
₹10Mkt Cap (₹ Cr.)
74.31P/E
134.71EPS
0.34Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 16.27 | 16.27 | 16.27 | 16.27 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1.93 | 1.03 | 0.56 | -0.14 |
Net Worth | 18.2 | 17.3 | 16.83 | 16.13 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 35.75 | 29.69 | 12.36 | 13.45 |
yoy growth (%) | 20.41 | 140.21 | -8.13 | 2.14 |
Raw materials | -32.42 | -25.3 | -9.77 | -8.51 |
As % of sales | 90.7 | 85.24 | 79.05 | 63.25 |
Employee costs | -0.75 | -0.86 | -0.72 | -0.53 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 1.91 | 1.46 | 0.58 | 2.31 |
Depreciation | -0.41 | -0.4 | -0.29 | -0.28 |
Tax paid | -0.67 | -0.25 | -0.11 | -0.51 |
Working capital | 1.16 | 0.5 | 0.52 | 1.66 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 20.41 | 140.21 | -8.13 | 2.14 |
Op profit growth | -12.25 | 95.02 | -64.33 | 200.94 |
EBIT growth | 25.32 | 114.6 | -70.13 | 118.38 |
Net profit growth | 2.83 | 156.46 | -73.76 | 129.25 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.4 | 95.58 | 4,08,666.73 | 2,000.46 | 0.94 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,790.5 | 81.57 | 1,80,131.05 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,482.4 | 24.88 | 1,19,745.08 | 1,485.4 | 1.08 | 4,254.47 | 397.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,504.6 | 62.68 | 1,18,597.8 | 474 | 0.17 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,639.3 | 57.84 | 1,08,985.15 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Ramesh Shah
Non Executive Director
Romil Shah
Independent Director
Satish Beohar
Independent Director
Ashok Kumar Ramawat
Whole-time Director
Ketan Shah
Independent Director
Gayatri Padiyar
Additional Director
Meet Shah
11/12 Sector E Sanwer Road,
Sanwer Road Industrial Area,
Madhya Pradesh - 452015
Tel: 91-731-2426700
Website: http://www.biofilgroup.net
Email: [email protected]; [email protected]
Plot No. 60,
Electronic Complex, Pardeshipura,
Indore - 452010
Tel: 91-0731-3198601/3198
Website: www.ankitonline.org
Email: [email protected]
Summary
Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.85 for manufacturing and trading of Pharmaceuticals products. Later on, the Company was convert...
Read More
Reports by Biofil Chemicals & Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.